AI Pathology Market Set to Grow 139% by 2035 as IT Spending Forecasts Cut
MSFT•The global AI in Pathology market is projected to climb from USD 28.75 million in 2025 to USD 68.81 million by 2035 at a 9.12% CAGR, despite IDC trimming U.S. IT spending growth forecasts. Geopolitical conflicts are disrupting cloud infrastructure and semiconductor supply chains, potentially pressuring MSFT's Azure AI deployment.
1. Market Projections
The AI in Pathology segment is valued at USD 28.75 million in 2025 and is forecast to reach USD 68.81 million by 2035, reflecting a compound annual growth rate of 9.12%. Rising demand for diagnostic automation underpins this expansion, driven by healthcare providers seeking scalable data analysis solutions.
2. Geopolitical Headwinds
Escalating tensions among the U.S., Israel and Iran have prompted IDC to lower its U.S. IT spending growth outlook, triggering delays in cloud infrastructure projects and bottlenecks in semiconductor component supplies. These disruptions risk slowing deployment schedules for large-scale AI workloads.
3. Implications for Azure
Microsoft’s Azure platform could face increased costs and project delays as cloud hardware orders compete with supply-constrained semiconductor inventories. Continued investment in AI infrastructure remains strong, but MSFT may need to adjust sourcing strategies or pricing to sustain enterprise adoption.
